We further delineated PSMC4’s functional roles through in vitro and in vivo studies on lung cancer cells, suggesting its utility in crafting targeted and personalized treatments that could enhance the prognosis of LUAD patients. This evidence concerns the gene PSMC4 and lung cancer.